Ilios Pharma Private Limited
About Ilios Pharma Private Limited
Data last updated:
Ilios Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 June 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304DL2018PTC335293. Its GSTIN is 07AAECI9075Q1ZQ (Delhi).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Prabha Devi Soni and Kamya Verma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 304 Corner T/F Floor Plot No – 1 Harsha Complex Dda Lsc Gazipur, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹70.9 Lakh, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹72,721 (net margin 1%) and EBITDA of ₹1.23 Lakh (EBITDA margin 1.7%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 10% over five years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address304 Corner T/F Floor Plot No – 1 Harsha Complex Dda Lsc Gazipur, New Delhi, Delhi, India – 110092
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ilios Pharma Private Limited
The main business activity of Ilios Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ilios Pharma Private Limited FY 2025 filings available
Ilios Pharma Private Limited reported revenue of ₹70.9 Lakh (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Ilios Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 10% growth in the latest year. EBITDA fell 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ilios Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.23 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹72,721 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ilios Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ilios Pharma are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Ilios Pharma Private Limited
Ilios Pharma has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prabha Devi Soni | Director | 27 Jul 2018 | 8 Years 2 Months | Current |
| Kamya Verma | Director | 27 Jul 2018 | 8 Years 2 Months | Current |
| Vipin Kumar Also directs: Ekanova Pharmaceuticals Private Limited | Director | 14 Jun 2018 | 8 Years 4 Months | Current |
| Ramjanki Swarnkar | Director | 14 Jun 2018 | 8 Years 4 Months | Current |
Peer Comparison of Ilios Pharma Private Limited
Ilios Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vishakha Wires Private Limited | ₹70.92 Lakh (FY 2025) | •••• | •••• | -28.0% | •••• | Indore, Madhya Pradesh, India |
| Sri Maa Power System Private Limited | ₹70.91 Lakh (FY 2025) | •••• | •••• | 54.0% | •••• | Patna, Bihar, India |
| Northern India Chemical Works Private Limited | ₹70.9 Lakh (FY 2025) | •••• | •••• | -11.0% | •••• | Uttar Pradesh, India |
| VHN Entity Private Limited | ₹70.9 Lakh (FY 2024) | •••• | •••• | -42.0% | •••• | Kolkata, West Bengal, India |
| Paridhan House Private Limited | ₹70.9 Lakh (FY 2021) | •••• | •••• | -14.0% | •••• | Kolkata, West Bengal, India |
| Ilios Pharma Private Limited this company | ₹70.9 Lakh (FY 2025) | •••• | •••• | 10.0% | •••• | New Delhi, Delhi, India |
| Way2print Private Limited | ₹70.89 Lakh (FY 2025) | •••• | •••• | -9.0% | •••• | Indore, Madhya Pradesh, India |
| Asm Minerals Private Limited | ₹70.89 Lakh (FY 2023) | •••• | •••• | 11.0% | •••• | Delhi, India |
| Varahaa Exports India Private Limited | ₹70.88 Lakh (FY 2025) | •••• | •••• | 39.0% | •••• | New Delhi, Delhi, India |
| C2b Engineering Private Limited | ₹70.87 Lakh (FY 2025) | •••• | •••• | 65.0% | •••• | Kolkata, West Bengal, India |
| I-Sphinx Private Limited | ₹70.84 Lakh (FY 2024) | •••• | •••• | 433.0% | •••• | Ghaziabad, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Ilios Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Ilios Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ilios Pharma Private Limited
Ilios Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Ilios Pharma Private Limited
Employment history and EPFO contributions of people linked to Ilios Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ilios Pharma Private Limited
Ilios Pharma Private Limited has 6 board changes on record since 2018: 5 appointments and 1 cessation. The latest: Vimlesh ceased to be Director on 22 Dec 2018.
Credit Ratings, Litigation & Regulatory Alerts for Ilios Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ilios Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ilios Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ilios Pharma Private Limited
Ilios Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECI9075Q1ZQ | Delhi | Active | 30 Oct 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ilios Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ilios Pharma Private Limited
Ilios Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 June 2018 (8+ years old) and is registered under CIN U24304DL2018PTC335293.
Ilios Pharma reported revenue of ₹70.9 Lakh for FY 2025 (up 10% YoY).
Ilios Pharma has 4 current directors:
- Prabha Devi Soni - Director
- Kamya Verma - Director
- Vipin Kumar - Director
- Ramjanki Swarnkar - Director
Ilios Pharma reported a net profit of ₹72,721 (net margin 1%) and EBITDA of ₹1.23 Lakh (EBITDA margin 1.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ilios Pharma is 2% over three years and 10% over five years. In the latest year (FY 2025) revenue rose 10%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Ilios Pharma is 07AAECI9075Q1ZQ, registered in Delhi.
The CIN (Corporate Identification Number) of Ilios Pharma is U24304DL2018PTC335293. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ilios Pharma was incorporated on 14 June 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Ilios Pharma by revenue are Vishakha Wires Private Limited, Sri Maa Power System Private Limited, Northern India Chemical Works Private Limited, VHN Entity Private Limited, Paridhan House Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Vimlesh ceased to be Director on 22 Dec 2018. Kamya Verma was appointed as Director on 27 Jul 2018. Prabha Devi Soni was appointed as Director on 27 Jul 2018. Ilios Pharma has 6 board changes on record in total.
The registered office of Ilios Pharma is at 304 Corner TF Floor Plot No – 1 Harsha Complex Dda Lsc Gazipur, New Delhi, Delhi, India – 110092.